Intuitive Machines has successfully launched its lunar lander, which, once it lands on the moon, would be the first commercial vehicle to do so. Photo via Intuitive Machines

Houston-based Intuitive Machines just made one giant leap for mankind.

On February 15, the space exploration, infrastructure, and services company successfully launched its IM-1 mission Nova-C class lunar lander on SpaceX’s Falcon 9 rocket. The launch followed a one-day delay.

The lunar touchdown of the Odysseus spacecraft is set for February 22, according to The Washington Post.

“If all goes well … it will become the first American spacecraft to gently set down on the moon’s surface since the Apollo 17 moon landing in 1972,” The New York Times notes.

It also would be the first commercial vehicle to land on the moon.

The IM-1 mission lander launched from NASA’s Kennedy Space Center in Florida at 12:05 a.m. CST. The lunar lander reached its orbit about 48 minutes later, and made its first communication with Intuitive Machines’ mission operations center in Houston at 12:59 a.m. CST.

The Intuitive Machines IM-1 mission is the company’s first attempted lunar landing as part of NASA’s Commercial Lunar Payload Services initiative, a key part of NASA’s Artemis moon exploration efforts. The science and technology payloads sent to the moon’s surface as part of the initiative are aimed at gearing up for human missions and a sustainable human presence on the moon’s surface.

NASA is the primary customer for this mission, paying Intuitive Machines $118 million to take its payloads to the moon’s surface, including a stereo camera to observe the plume of dust kicked up during landing and a radio receiver to measure the effects of charged particles on radio signals, according to The Times. Also aboard is cargo such as a camera built by students at Embry-Riddle Aeronautical University in Daytona Beach, Florida, and the Moon Phases project by American artist Jeff Koons.

“We are keenly aware of the immense challenges that lie ahead,” Steve Altemus, co-founder, president and CEO of Intuitive Machines, says in a news release. “However, it is precisely in facing these challenges head-on that we recognize the magnitude of the opportunity before us: to softly return the United States to the surface of the Moon for the first time in 52 years.”

The liftoff of the IM-1 mission was targeted for a multiday launch window that opened at 11:57 p.m. CST on February 13. Intuitive Machines and SpaceX had concluded pre-launch testing on February 12.

“I feel fairly confident that we’re going to be successful softly touching down on the moon,” Altemus told The New York Times. “We’ve done the tests. We tested and tested and tested. As much testing as we could do.”

Last year, Intuitive Machines went public through a SPAC (special purpose acquisition company) merger with Inflection Point Acquisition Corp. The Houston company’s stock trades on the NASDAQ stock market. Following the launch of the lunar lander, Intuitive Machines saw a spike in its stock price on February 15.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”